IWB vs XBI

iShares Russell 1000 ETF vs SPDR S&P Biotech ETF

Quick take
  • IWB has the lower expense ratio at 0.15% vs 0.35% for XBI.
  • IWB pays a higher dividend yield (0.92%).

Side-by-side metrics

MetricIWBXBI
Expense ratio
Annual fee. Lower is better.
0.15%0.35%
Dividend yield
Trailing 12-month yield.
0.92%0.36%
AUM
Assets under management — bigger funds are typically more liquid.
$48.33B$10.73B
YTD return
9.81%33.79%
1-year return
3-year return
Annualized.
5-year return
Annualized.
10-year return
Annualized.
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
1.011.10
P/E ratio
26.69
Last price
$411.81$164.01
Inception
Issuer
iSharesState Street

IWB top holdings

Top holdings · IWB
NVDANVIDIA Corp6.72%
AAPLApple Inc6.03%
MSFTMicrosoft Corp3.99%
AMZNAmazon.com Inc3.33%
GOOGLAlphabet Inc Class A3.00%
AVGOBroadcom Inc2.53%
GOOGAlphabet Inc Class C2.42%
MUMicron Technology Inc1.87%
METAMeta Platforms Inc Class A1.78%
TSLATesla Inc1.77%
Sector breakdown · IWB
Real Estate2.1%
Consumer Cyclical9.6%
Basic Materials1.9%
Consumer Defensive4.4%
Technology36.6%
Communication Services9.6%
Financial Services11.7%
Utilities2.2%
Industrials9.7%
Energy3.0%
Healthcare9.1%

XBI top holdings

Top holdings · XBI
APGEApogee Therapeutics Inc1.49%
MRNAModerna Inc1.41%
TWSTTwist Bioscience Corp1.41%
ORKAOruka Therapeutics Inc1.38%
KYMRKymera Therapeutics Inc Ordinary Shares1.36%
VKTXViking Therapeutics Inc1.30%
PRAXPraxis Precision Medicines Inc Ordinary Shares1.29%
ERASErasca Inc1.27%
RVMDRevolution Medicines Inc Ordinary Shares1.20%
RYTMRhythm Pharmaceuticals Inc1.20%
Sector breakdown · XBI
Financial Services0.5%
Healthcare99.5%

About IWB

IWB (iShares Russell 1000 ETF) is Largest 1,000 US stocks. Managed by iShares, the fund carries $48.3B in assets under management, an expense ratio of 0.15%, a dividend yield of 0.92%. Its largest holding is NVIDIA Corp (NVDA), which represents 6.7% of the portfolio. Real Estate is the fund's largest sector exposure at 2.1%.

About XBI

XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.